Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
21.82
+0.56 (2.63%)
At close: Aug 21, 2026, 4:00 PM EDT
22.10
+0.28 (1.28%)
After-hours: Aug 21, 2026, 7:41 PM EDT

Legend Biotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,2711,029627.3285.1117.0168.83
Revenue Growth
59.55%64.02%120.03%143.66%70.00%-8.23%
Gross Profit
719.3620.8392.7140.951.6468.83
Operating Income
-52.8-136.5-305.1-528.1-458.05-394.02
Net Income
-91.5-296.8-177-518.3-446.35-403.58
Earnings Per Share
-0.50-1.62-0.97-2.94-2.81-2.87
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
License
107.1883.8138.435.165065.4
Collaboration
1,164944.8482.58249.866.68-
Other Service
-0.36.260.180.333.42
Revenue (Total)
1,2711,029627.3285.1117.0168.83

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
964.6948.61,1231,3091,026882.4
Total Debt
278.2413.7350.6328.67284.53122.97
Net Cash (Debt)
686.4534.9772980.05741.12759.43
Net Cash Growth
18.42%-30.71%-21.23%32.24%-2.41%51.28%
Net Cash Per Share
3.702.904.225.574.665.39

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-89.4-100.2-144-393.3-201.28-198.47
Capital Expenditures
-32.4-28.6-14.1-20.1-20.93-42.2
Free Cash Flow
-121.8-128.8-158.1-413.4-222.21-240.66
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
56.57%60.34%62.60%49.42%44.14%100.00%
Operating Margin
-4.15%-13.27%-48.64%-185.23%-391.48%-572.49%
Pretax Margin
-4.42%-27.47%-25.20%-182.46%-380.94%-591.63%
Profit Margin
-7.20%-28.85%-28.22%-181.80%-381.48%-586.38%
FCF Margin
-9.58%-12.52%-25.20%-145.00%-189.91%-349.67%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
49.59150.43----
PS Ratio
3.333.909.5238.3771.42104.26